12月9日，永和智控（002795）发布公告，关于公开挂牌转让公司全资孙公司昆明医科肿瘤医院有限公司100%股权的进展情况。 为继续推进转让事项，公司将第四次挂牌底价下调60%至1220万元，公示期为2025年12月9日至2025年12月15日。 近年来，永和智控业绩承压，2022年~2024年分别净亏损2618.67万元、1.56亿元、2.97亿元。今年以来永和智控频繁挂牌转让子公司，或是为了"割肉求 生"。 最新业绩显示，2025年前三季度，永和智控实现营业收入为5.82亿元，同比下降7.2%；归母净利润自去年同期亏损7620万元变为亏损6046万元，亏损额有 所减少；扣非归母净利润自去年同期亏损7591万元变为亏损5294万元，亏损额有所减少；经营现金流净额为4789万元，同比增长162.6%；EPS(全面摊薄) 为-0.1356元。 其中第三季度，公司营业收入为2.15亿元，同比上升4.3%；归母净利润自去年同期亏损1996万元变为亏损2284万元，亏损额进一步扩大；扣非归母净利润 自去年同期亏损2047万元变为亏损1774万元，亏损额有所减少；EPS为-0.0512元。 ↓↓↓ 公司于2025年11 ...

永和流体智控股份有限公司 关于公开挂牌转让普乐新能源科技（泰兴）有限公司51%股权 及债权的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、交易概述 永和流体智控股份有限公司（以下简称"公司"）于 2025 年 10 月 10 日、2025 年 10 月 29 日召开第五届董事会第二十二次临时会议、第五届监事会第十七次临时会议 及 2025 年第二次临时股东大会，审议通过了《关于拟公开挂牌转让普乐新能源科技 （泰兴）有限公司 51%股权及债权的议案》，同意公司在产权交易所公开挂牌转让 控股子公司普乐新能源科技（泰兴）有限公司（以下简称"泰兴普乐"）51%股权及公 司对泰兴普乐的全部债权，并同意授权公司董事长或董事长授权的代理人负责具体实 施 该 事 项 。 具 体 内 容 详 见 公 司 于 2025 年 10 月 14 日 在 巨 潮 资 讯 网 （http://www.cninfo.com.cn）、《证券时报》和《证券日报》刊登的《关于拟公开挂 牌转让普乐新能源科技（泰兴）有限公司 51%股权及债权的公告》（公告编号： 2025-041）。 ...

证券代码：002795 证券简称：永和智控 公告编号：2025-077 永和流体智控股份有限公司 1 价格基础上下调 20%进行第二次挂牌，第二次挂牌转让底价为 2,874.216 万元。挂牌 公示期为 2025 年 12 月 9 日起至 2025 年 12 月 15 日止。 三、风险提示 关于公开挂牌转让昆明医科肿瘤医院有限公司100%股权的 进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、交易概述 永和流体智控股份有限公司（以下简称"公司"）于 2025 年 11 月 18 日召开第五 届董事会第二十六次临时会议、第五届监事会第二十次临时会议，审议通过了《关于 拟公开挂牌转让昆明医科肿瘤医院有限公司 100%股权的议案》，同意公司在产权交 易所公开挂牌转让全资孙公司昆明医科肿瘤医院有限公司（以下简称"昆明医科"） 100%股权，并同意授权公司董事长或董事长授权的代理人负责具体实施该事项。具 体内容详见公司于 2025 年 11 月 19 日在巨潮资讯网（http://www.cninfo.com.cn）、 《证券时报》和《证券日报》刊登的《关 ...

Core Insights - Recent announcements from Yonghe Zhikong and Dadongfang reveal significant low-price disposals of their private hospitals, indicating a distress in the healthcare sector [3][8] - Yonghe Zhikong has been unable to attract buyers for its hospitals, with prices dropping drastically, exemplified by a 90% reduction in the valuation of Dazhou Medical Oncology Hospital [6][7] - Dadongfang is also divesting underperforming assets, including a hospital sold for just 1 yuan, reflecting challenges in the healthcare market [8][11] Yonghe Zhikong Overview - Yonghe Zhikong has been attempting to pivot towards the healthcare sector since 2019, acquiring several oncology hospitals to enhance profitability [3][4] - Despite these efforts, the revenue from medical services has remained low, peaking at approximately 148 million yuan in 2023, which constituted about 15.57% of total revenue [4] - The company has faced continuous losses from its hospital operations, with Dazhou Medical Oncology Hospital reporting a net loss of 706,000 yuan in 2024 [6][7] Financial Performance and Asset Disposals - Yonghe Zhikong's attempts to sell its hospitals have seen significant price reductions, with the Dazhou Medical Oncology Hospital's share price dropping from 27.67 million yuan to 2.77 million yuan [5][6] - The company has also listed other hospitals for sale, including the Kunming Medical Oncology Hospital, which is being offered at 33% of its original acquisition price [5][6] - The financial struggles of these hospitals are evident, with all four hospitals listed for sale reporting ongoing losses and one having negative net assets [5][6][7] Dadongfang Overview - Dadongfang has been strategically divesting certain underperforming hospital assets, including the sale of Jin Hua Lian Ji Hospital for 1 yuan [8][11] - The company has expanded its healthcare services through acquisitions since 2022, focusing on pediatric care and other medical services [9][10] - Despite growth in revenue from pediatric services, the overall profitability remains low, with significant fixed costs impacting financial performance [10][11] Market Challenges - Both companies are facing challenges due to changes in healthcare policies and market conditions, leading to declining revenues and increased operational losses [11] - The healthcare sector is experiencing a shift, with companies needing to adapt to new economic realities and consumer demands to remain viable [9][10]

Key Points - Company Grinda plans to invest 80 million yuan to subscribe for 1.91% of Muxi's initial public offering shares [1] - Fuyong Technology clarifies that its products do not possess AI capabilities [1] - Bohui Paper Industry intends to invest 1.7 billion yuan to establish a project with an annual production capacity of 320,000 tons of chemical pulp [1] - Jinggong Technology has won the bid for the Wuhan Qingshan high-performance carbon fiber production base project [1] - Yonghe Intelligent Control plans to transfer 100% equity and debt of its wholly-owned subsidiary Chengdu Shanshui [2] - Zhigang Home plans to repurchase shares with an investment of 80 million to 110 million yuan [2] - Meikailong's shareholder Hangzhou Haoyue intends to reduce its holdings by no more than 131 million shares [2] - International Medical plans to raise no more than 1.008 billion yuan through a private placement [2] - Guizhou Bailin's actual controller Jiang Wei has received a notice of investigation from the Securities Regulatory Commission [2]

Group 1 - Yonghe Intelligent Control plans to publicly transfer 100% equity and a debt of 114 million yuan of its subsidiary Chengdu Shanshuishang Hotel, with a minimum listing price of 185 million yuan [1] - Grinda intends to invest 79.9999 million yuan to subscribe for 764,400 shares of Muxi Integrated Circuit (Shanghai) Co., accounting for 0.19% of the total share capital after issuance [1] - Tianshan Aluminum's actual controllers plan to reduce their holdings by no more than 1% of the company's shares starting from December 25, 2025 [1][2] Group 2 - Guang'an Aizhong plans to publicly issue bonds not exceeding 1 billion yuan to repay debts and supplement working capital [3] - Tengda Technology's shareholder plans to reduce holdings by no more than 0.8% of the company's shares starting from December 26, 2025 [4] - Tianwo Technology intends to invest in a 300,000-kilowatt "solar thermal + wind power integration" project with a total investment not exceeding 1.918 billion yuan [5][6] Group 3 - Yunnan Energy Investment announces that three wind power expansion projects have achieved full capacity grid connection, adding 596,250 kilowatts of wind power capacity [7] - Jinggong Technology wins a bid for a carbon fiber production base project worth 729 million yuan, accounting for 42.16% of its audited revenue for 2024 [8] - CITIC Bank's risk director's qualification has been approved by the regulatory authority [9][10] Group 4 - Electric Media plans to establish a joint venture with Mango Super Media and Zhangjiajie Tourism Group with a registered capital of 180 million yuan [11] - New Lai Ying Material's subsidiary plans to invest 157 million yuan to acquire a 51% stake in Anpu Intelligent Technology [13] - Kuaiji Elevator has been notified of the cancellation of its high-tech enterprise qualification for 2021-2023, which may impact its operating performance [15] Group 5 - Huakai Yibai's shareholders plan to reduce their holdings by no more than 2.94% of the company's shares [16] - Del Shares' shareholder plans to reduce holdings by no more than 2.98% of the company's shares [17] - Rifa Precision plans to sell idle assets for 155 million yuan to an affiliated party [19] Group 6 - Wanlong Optoelectronics is planning a major asset restructuring and has suspended trading of its shares [20] - Bangjie Co.'s shareholder plans to reduce holdings by no more than 400,000 shares [22] - Nanhua Instrument's actual controller and related parties plan to reduce holdings by no more than 1.62% of the company's shares [24] Group 7 - Unisplendour has re-submitted its H-share listing application to the Hong Kong Stock Exchange [25] - Zhongshi Technology plans to acquire 51% of Zhongshi Xun Cold for 35.7 million yuan [26] - Pulutong is planning a major asset restructuring and has suspended trading of its shares [26]

Core Viewpoint - Yonghe Intelligent Control plans to publicly transfer 100% equity of its wholly-owned subsidiary Chengdu Mountain Water Hotel Co., Ltd. and the debt owed by Chengdu Yonghe Cheng Medical Technology Co., Ltd. to Chengdu Mountain Water, with a minimum initial listing price of 185 million yuan, aiming to optimize asset structure, improve cash flow, and enhance asset operation efficiency [1][2]. Group 1: Company Actions - The company is transferring the equity and debt to improve its asset structure and cash flow [1]. - This is not the first time the company has attempted to transfer Chengdu Mountain Water, as previous attempts were made in late 2024 to early 2025, but those transactions did not succeed [2]. - The company has been divesting from its underperforming assets in the tumor precision radiation treatment and photovoltaic sectors, including multiple hospitals and its stake in Puluo Technology [3]. Group 2: Financial Performance - As of July 2025, Chengdu Mountain Water had total assets of 108 million yuan, total liabilities of 126 million yuan, and negative equity of 1.77 million yuan [2]. - For the fiscal year 2024, Chengdu Mountain Water reported revenue of 19.51 million yuan and a net profit of 3.52 million yuan, with revenue and net profit for the first seven months of this year at 9.59 million yuan and 1.42 million yuan, respectively [2]. - Yonghe Intelligent Control reported a revenue of 582 million yuan for the first three quarters of this year, a year-on-year decrease of 7.25%, and a net loss of 60.46 million yuan [3].

Core Viewpoint - Yonghe Intelligent Control (002795.SZ) plans to publicly transfer 100% equity of its wholly-owned subsidiary Chengdu Shanshui Shang and the debt owed by its wholly-owned subsidiary Chengdu Yonghe Cheng to Chengdu Shanshui Shang to optimize asset structure, improve cash flow, and enhance asset operation efficiency [1] Group 1: Transaction Details - The company has commissioned Yinxin Asset Appraisal Co., Ltd. to evaluate the total equity value of Chengdu Shanshui Shang, which, as of the evaluation benchmark date of July 31, 2025, has an audited net asset value of -17.71 million yuan [1] - The market value of the total equity of Chengdu Shanshui Shang is appraised at 70.39 million yuan, while the total debt owed by Chengdu Yonghe Cheng to Chengdu Shanshui Shang amounts to 114.48 million yuan [1] - The initial public transfer price for the 100% equity of Chengdu Shanshui Shang and the debt is set at no less than 184.87 million yuan [1] Group 2: Post-Transaction Impact - Upon completion of this transaction, the company will no longer hold any equity in Chengdu Shanshui Shang, and Chengdu Shanshui Shang will be excluded from the company's consolidated financial statements [1]

Core Viewpoint - The company Yonghe Intelligent Control (002795.SZ) plans to publicly transfer 100% equity of its wholly-owned subsidiary Chengdu Mountain Water and the debt owed by its wholly-owned subsidiary Chengdu Yonghe Cheng to Chengdu Mountain Water in order to optimize its asset structure, improve cash flow, and enhance asset operation efficiency [1] Group 1: Transaction Details - The company has commissioned Yinxin Asset Appraisal Co., Ltd. to evaluate the total equity value of Chengdu Mountain Water, which as of the evaluation benchmark date of July 31, 2025, has an audited net asset value of -17.71 million yuan [1] - The market value of the total equity of Chengdu Mountain Water is appraised at 70.39 million yuan, while the total debt owed by Chengdu Yonghe Cheng to Chengdu Mountain Water amounts to 114.48 million yuan [1] - The initial public transfer price for the 100% equity of Chengdu Mountain Water and the debt is set at no less than 184.87 million yuan [1] Group 2: Impact on Financial Reporting - Upon completion of this transaction, the company will no longer hold any equity in Chengdu Mountain Water, and it will be excluded from the company's consolidated financial statements [1]

Core Viewpoint - Yonghe Intelligent Control (002795.SZ) announced the public transfer of 100% equity of its wholly-owned subsidiary Chengdu Shanshui Shang Hotel Co., Ltd. and the debt owed by its wholly-owned subsidiary Chengdu Yonghe Cheng Medical Technology Co., Ltd. to Chengdu Shanshui Shang, with a minimum initial listing price of no less than RMB 185 million [1] Group 1 - The company plans to publicly transfer the entire equity of Chengdu Shanshui Shang Hotel [1] - The transfer includes the debt owed by Chengdu Yonghe Cheng Medical Technology to Chengdu Shanshui Shang [1] - The total minimum listing price for the equity and debt is set at RMB 185 million [1]